331 related articles for article (PubMed ID: 1679378)
1. Analyses of acute graft-versus-host-like reaction in [MRL/lpr----MRL/+] chimeric mice using MRL/lpr-Thy-1. 1 congenic mice.
Nakagawa T; Nagata N; Hosaka N; Inaba M; Yasumizu R; Ogawa R; Ikehara S
Cell Immunol; 1991 Oct; 137(1):189-99. PubMed ID: 1679378
[TBL] [Abstract][Full Text] [Related]
2. Analyses of lpr-GVHD by adoptive transfer experiments using MRL/lpr-Thy-1.1 congenic mice.
Hosaka N; Nagata N; Nakagawa T; Miyashima S; Yasumizu R; Ikehara S
Autoimmunity; 1994; 17(3):217-24. PubMed ID: 7948606
[TBL] [Abstract][Full Text] [Related]
3. Auto-MHC class II-reactive T cell line obtained from MRL/+ mice suffering from lpr-GVHD. II. Analyses of functional characteristics of T cell line by in vivo administration.
Nagata N; Nakagawa T; Hosaka N; Ikehara S
Immunobiology; 1992 Nov; 186(5):339-50. PubMed ID: 1286875
[TBL] [Abstract][Full Text] [Related]
4. Auto-MHC class II-reactive T cell line obtained from MRL/+mice suffering from "lpr-GVHD". I. Characterization of surface phenotypes, specificities and functions in vitro.
Nagata N; Yasumizu R; Ohnishi Y; Nakagawa T; Inaba M; Ikehara S
Immunobiology; 1990 Nov; 181(4-5):367-78. PubMed ID: 2099906
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of lpr-graft-versus-host disease (GVHD) in MRL/lpr spleen cell-injected SCID mice by in vivo treatment with anti-V beta 8.1,2 monoclonal antibody.
Hosaka N; Nagata N; Miyashima S; Ikehara S
Clin Exp Immunol; 1994 Jun; 96(3):500-7. PubMed ID: 8004820
[TBL] [Abstract][Full Text] [Related]
6. Comparison of wasting syndrome in [MRL lpr/lpr-->MRL +/+] chimera and graft versus host disease in [B10.D2-->BALB/c] chimera and an attempt to transfer the wasting syndrome in [MRL lpr/lpr-->MRL +/+] to MRL +/+ mice.
Aihara M; Aihara Y; Nakajima H
J Dermatol Sci; 1994 Apr; 7(2):107-18. PubMed ID: 7914743
[TBL] [Abstract][Full Text] [Related]
7. Selective elimination of non-lpr lymphoid cells in mice undergoing lpr-mediated graft-vs-host disease.
Perkins DL; Michaelson J; Glaser RM; Marshak-Rothstein A
J Immunol; 1987 Sep; 139(5):1406-13. PubMed ID: 2887617
[TBL] [Abstract][Full Text] [Related]
8. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
9. Defect in negative selection in lpr donor-derived T cells differentiating in non-lpr host thymus.
Matsumoto K; Yoshikai Y; Asano T; Himeno K; Iwasaki A; Nomoto K
J Exp Med; 1991 Jan; 173(1):127-36. PubMed ID: 1670637
[TBL] [Abstract][Full Text] [Related]
10. Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.
Hosaka N; Ryu T; Miyake T; Cui W; Nishida T; Takaki T; Inaba M; Ikehara S
Clin Exp Immunol; 2007 Mar; 147(3):555-63. PubMed ID: 17302907
[TBL] [Abstract][Full Text] [Related]
11. Suppressor T-cell activity in MRL/Mp-lpr/lpr mice: differential effects on primary and memory antibody responses of MRL/Mp-lpr/lpr and MRL/Mp-+/+ spleen cells to thymus dependent and thymus independent antigens in vitro.
Wilson DA
Cell Immunol; 1985 Dec; 96(2):312-26. PubMed ID: 2943418
[TBL] [Abstract][Full Text] [Related]
12. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H
Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the existence of two parallel differentiation pathways in the thymus of MRL lpr/lpr mice.
Matsuzaki Y; Pannetien C; Kanagawa O; Gachelin G; Nakauchi H
J Immunol; 1992 Aug; 149(3):1069-74. PubMed ID: 1378863
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of self-reactive T cell receptor V beta regions in autoimmune mice.
Mountz JD; Smith TM; Toth KS
J Immunol; 1990 Mar; 144(6):2159-66. PubMed ID: 1690237
[TBL] [Abstract][Full Text] [Related]
15. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S
J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497
[TBL] [Abstract][Full Text] [Related]
16. Resistance to lymphoid engraftment in lpr recipients of normal bone marrow: characterization of chimeric stem cell, monocyte and peripheral lymphoid lineages.
Glaser RM; Marshak-Rothstein A
Eur J Immunol; 1990 Sep; 20(9):1917-25. PubMed ID: 2209698
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
[TBL] [Abstract][Full Text] [Related]
18. CD4-CD8- thymocytes from MRL-lpr/lpr mice exhibit abnormal proportions of alpha beta- and gamma delta-TCR+ cells and demonstrate defective responsiveness when activated through the TCR.
Kakkanaiah VN; Nagarkatti M; Bluestone JA; Nagarkatti PS
Cell Immunol; 1991 Oct; 137(2):269-82. PubMed ID: 1832583
[TBL] [Abstract][Full Text] [Related]
19. One-way occurrence of graft-versus-host disease in bone marrow chimaeras between congenic MRL mice.
Fujiwara M; Kariyone A
Immunology; 1984 Oct; 53(2):251-6. PubMed ID: 6237981
[TBL] [Abstract][Full Text] [Related]
20. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation.
Kushida T; Inaba M; Takeuchi K; Sugiura K; Ogawa R; Ikehara S
Blood; 2000 Mar; 95(5):1862-8. PubMed ID: 10688849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
